Amcasertib Uses, Dosage, Side Effects and more
Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Amcasertib |
| Generic | Amcasertib |
| Amcasertib Other Names | Amcasertib |
| Type | |
| Formula | C31H33N5O2S |
| Weight | Average: 539.7 Monoisotopic: 539.235496497 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
